Riverview Trust CO Laboratory Corp Of America Holdings Transaction History

Riverview Trust CO

7 transactions

Quarter	Operation	Price Per share	shares change	shares Held
Q1 2024 Apr 12, 2024	BUY	$209.01 - $232.56 $12,958 - $14,418	62 New	62 $13,000
Q2 2023 Jul 17, 2023	SELL	$211.93 - $241.33 $71,632 - $81,569	-338 Reduced 84.5%	62 $14,000
Q1 2023 Apr 20, 2023	SELL	$213.32 - $257.83 $85,328 - $103,132	-400 Reduced 50.0%	400 $91,000
Q4 2022 Jan 25, 2023	SELL	$203.72 - $248.97 $10,797 - $13,195	-53 Reduced 6.21%	800 $188,000
Q3 2022 Oct 27, 2022	BUY	$204.81 - $262.19 $10,854 - $13,896	53 Added 6.63%	853 $175,000
Q2 2022 Jul 27, 2022	BUY	$213.86 - $277.87 $153,551 - $199,510	718 Added 875.61%	800 $187,000
Q1 2022 Apr 21, 2022	BUY	$259.82 - $298.18 $21,305 - $24,450	82 New	82 $22,000

128

2.48M

Ticker LH
Exchange NYSE
Sector Healthcare
Industry Diagnostics & Research
Shares Outstandng 89,600,000
Market Cap $19.6B
Description
Laboratory Corporation of America Holdings operates as a global life sciences company that provides vital information to help doctors, hospitals, pharmaceutical companies, researchers, and patients make clear and confident decisions. It operates in two segments, Labcorp Diagnostics (Dx) and Labcorp Drug Development (DD). It offers various tests,...

Get notified when there are updates to the investment portfolio of Riverview Trust CO, based on Form 13F filings with the SEC.

Stay updated on Riverview Trust CO with notifications on news.